Early Health

What Early Health does

Early Health Ltd is a London-based, privately held seed-stage startup developing consumer-facing self-diagnostic medical devices based on urine analysis. Founded in 2022, the company is building hardware intended to enable health-conscious consumers to perform at-home diagnostic testing and receive health insights without visiting a clinical laboratory. The company's core product, branded under the DBA "Early.", is a self-diagnostic urine test device positioned for preventive health screening and early illness detection, with a website (earlyhealth.com) currently in a pre-launch "waitlist incoming" state rather than actively transacting.

The technology stack centers on a proprietary urine-based diagnostic platform that the company describes as a domain-specialized innovation in consumer health diagnostics, with no disclosed patents, trademarks, certifications, or regulatory clearances in the input data. The company has received venture backing — approximately $4.68M in a 2023 round led by LocalGlobe with participation from SoftBank Vision Fund, Atomico, and Creator Fund, plus a 2026 seed from Crit Ventures — and operates with 1–10 employees from a headquarters at 11-21 Northdown Street, London, N1.

The intended business model is direct-to-consumer hardware sales, with the company building its own e-commerce channel on earlyhealth.com and capturing pre-launch demand through a waitlist. No pricing has been publicly disclosed, there are no named customers or distribution partners, and the company has stated primary use cases of self-diagnostic health monitoring, at-home urine testing, and preventive health screening aimed at health-conscious consumers facing accessibility barriers to traditional lab-based diagnostics.

Name

Early Health

Legal name

Early Health Ltd

Website

https://earlyhealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Early Health is a London-based seed-stage startup developing a self-diagnostic urine test device for at-home health monitoring. The company targets health-conscious consumers, operates a D2C pre-launch model, and has not yet released a commercial product.

Ownership category

akta.pro rank

Product category

Consumer Health Diagnostics

NAICS

Medical Equipment and Supplies Manufacturing (3391), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Urinalysis & Routine Screening Diagnostics (HLAHAAAG)

akta.pro secondary industries

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

Keywords

• Consumer diagnostics
• Urine testing
• At-home health monitoring
• Self-diagnostic devices
• Preventive health screening

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Diagnostic Device Sales: Early Health generates revenue through the sale of self-diagnostic urine test devices. As a seed-stage company in development, the primary revenue stream is expected to be product sales of consumer-facing diagnostic devices.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

Early Health is developing consumer-facing self-diagnostic hardware devices that analyze urine samples to deliver at-home health monitoring and early illness detection. The company is currently pre-launch, capturing consumer interest through a waitlist, and intends to sell these diagnostic devices directly to individuals via its own e-commerce storefront.

Product overview

Early Health is developing a self-diagnostic device based on urine tests, currently in pre-launch phase with a waitlist available. The company received seed funding from Crit Ventures in February 2026 to advance development of this diagnostic technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Early Health Self-Diagnostic Device A consumer-facing diagnostic device that uses urine analysis to enable at-home self-testing for health monitoring and early illness detection, intended for health-conscious individual consumers who want to track health status without visiting a clinical laboratory.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves4 records

Direct peers

• Healthy.io: Healthy.io offers smartphone-based urinalysis testing for clinical and consumer use, including UTI and kidney function screening. It is the most direct comparator to Early Health's at-home urine diagnostics concept and has regulatory clearance in multiple markets.
• Scanwell Health: Scanwell Health develops smartphone-based at-home diagnostic tests including urinalysis for UTIs. Its direct-to-consumer model and urine focus closely mirror Early Health's intended go-to-market.
• Thriva: Thriva is a UK-based home diagnostics company offering finger-prick blood tests with a subscription model. It is a strong comparable for Early Health on geography, DTC positioning, and the broader home-diagnostic consumer category.

Broad incumbents

• LetsGetChecked: LetsGetChecked is a scaled at-home diagnostics platform offering a broad panel of tests with telehealth integration. It competes in the same consumer category as Early Health with significantly more scale, regulatory coverage, and product breadth.
• Withings: Withings is an established consumer health hardware brand producing connected scales, blood pressure monitors, and sleep devices. It is comparable as a precedent for consumer-grade health hardware reaching the bathroom, though it does not currently offer urine diagnostics.
• Abbott (Lingo and consumer diagnostics): Abbott operates consumer health diagnostics brands including Lingo (metabolic biosensor) and Binax (rapid tests). It is comparable as a large incumbent pushing consumer diagnostics hardware into the home, with vastly greater regulatory and commercial resources.

Emerging players

• Cue Health: Cue Health developed a connected at-home molecular diagnostics platform. It is comparable on connected consumer diagnostics hardware and regulatory complexity, though its focus has been on infectious disease rather than urine analysis.
• myLAB Box: myLAB Box offers at-home screening tests including UTI and other urine-based panels sold DTC. It overlaps directly with Early Health's intended use case at a smaller scale than LetsGetChecked.
• Levels: Levels sells a continuous glucose monitor paired with software for metabolic health. It is comparable as a venture-backed DTC consumer diagnostics hardware brand pursuing proactive health monitoring — a similar value proposition to Early Health.

Others

• BlueLoop by BVI Medical (urine diagnostics): BVI Medical manufactures clinical urinalysis devices and consumables for healthcare settings. It is comparable as an adjacent urinalysis technology provider, useful as a reference for what regulated urine diagnostics hardware looks like at scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/early-health-limited

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Early Health